Pippin JW - Search Results

1

The emergence of the glomerular parietal epithelial cell.

Shankland SJ, Smeets B, Pippin JW, Moeller MJ. Shankland SJ, et al. Among authors: pippin jw. Nat Rev Nephrol. 2014 Mar;10(3):158-73. doi: 10.1038/nrneph.2014.1. Epub 2014 Jan 28. Nat Rev Nephrol. 2014. PMID: 24468766 Review.

2

Urinary eicosanoids and the assessment of glomerular inflammation.

Lefkowith JB, Pippin J, Nagamatsu T, Lee V. Lefkowith JB, et al. J Am Soc Nephrol. 1992 May;2(11):1560-7. doi: 10.1681/ASN.V2111560. J Am Soc Nephrol. 1992. PMID: 1319219

3

SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits platelet-derived-growth-factor-medicated mesangial cell proliferation in vitro.

Pichler RH, Bassuk JA, Hugo C, Reed MJ, Eng E, Gordon KL, Pippin J, Alpers CE, Couser WG, Sage EH, Johnson RJ. Pichler RH, et al. Am J Pathol. 1996 Apr;148(4):1153-67. Am J Pathol. 1996. PMID: 8644857 Free PMC article.

4

Differential expression of transforming growth factor-beta isoforms and receptors in experimental membranous nephropathy.

Shankland SJ, Pippin J, Pichler RH, Gordon KL, Friedman S, Gold LI, Johnson RJ, Couser WG. Shankland SJ, et al. Kidney Int. 1996 Jul;50(1):116-24. doi: 10.1038/ki.1996.294. Kidney Int. 1996. PMID: 8807580

5

Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis.

Shankland SJ, Hugo C, Coats SR, Nangaku M, Pichler RH, Gordon KL, Pippin J, Roberts JM, Couser WG, Johnson RJ. Shankland SJ, et al. Kidney Int. 1996 Oct;50(4):1230-9. doi: 10.1038/ki.1996.432. Kidney Int. 1996. PMID: 8887282

6

Beneficial effects of systemic immunoglobulin in experimental membranous nephropathy.

Nangaku M, Pippin J, Richardson CA, Schulze M, Young BA, Alpers CE, Gordon KL, Johnson RJ, Couser WG. Nangaku M, et al. Kidney Int. 1996 Dec;50(6):2054-62. doi: 10.1038/ki.1996.529. Kidney Int. 1996. PMID: 8943490

7

A new model of renal microvascular endothelial injury.

Nangaku M, Alpers CE, Pippin J, Shankland SJ, Adler S, Kurokawa K, Couser WG, Johnson RJ. Nangaku M, et al. Kidney Int. 1997 Jul;52(1):182-94. doi: 10.1038/ki.1997.318. Kidney Int. 1997. PMID: 9211361

8

Cyclin kinase inhibitors are increased during experimental membranous nephropathy: potential role in limiting glomerular epithelial cell proliferation in vivo.

Shankland SJ, Floege J, Thomas SE, Nangaku M, Hugo C, Pippin J, Henne K, Hockenberry DM, Johnson RJ, Couser WG. Shankland SJ, et al. Kidney Int. 1997 Aug;52(2):404-13. doi: 10.1038/ki.1997.347. Kidney Int. 1997. PMID: 9263996

9

Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with Roscovitine, a novel cyclin-dependent kinase antagonist.

Pippin JW, Qu Q, Meijer L, Shankland SJ. Pippin JW, et al. J Clin Invest. 1997 Nov 15;100(10):2512-20. doi: 10.1172/JCI119793. J Clin Invest. 1997. PMID: 9366565 Free PMC article.

10

Renal microvascular injury induced by antibody to glomerular endothelial cells is mediated by C5b-9.

Nangaku M, Alpers CE, Pippin J, Shankland SJ, Kurokawa K, Adler S, Johnson RJ, Couser WG. Nangaku M, et al. Kidney Int. 1997 Dec;52(6):1570-8. doi: 10.1038/ki.1997.487. Kidney Int. 1997. PMID: 9407502

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results